Did you analyze how IQVIA Holdings (IQV) fared in its international operations for the quarter ending June 2025? Given the widespread global presence of this clinical testing company, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become ess ...

IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped estimates. https://t.co/RpNKde2yOG ...

Group 1 - The article discusses IQVIA Holdings Inc.'s recent performance, highlighting a revenue of $3.83 billion in Q1, which was driven by growth in the Technology & Analytics Solutions (TAS) segment [1] - The author emphasizes the importance of innovative companies in the biotech and pharmaceutical sectors, particularly those developing breakthrough therapies with potential acquisition catalysts [1] Group 2 - The article is part of a subscription marketplace service called Compounding Healthcare, which offers model healthcare portfolios, a weekly newsletter, and a daily watchlist for investors [1]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-35907 _________________________________________________________ IQVIA HOLDINGS INC. (Exact name of registrant as specified in its charter) _____________ ...

Key Takeaways IQV's Q2 adjusted EPS rose 6.4% y/y to $2.81 on $4B in revenues, both beating estimates. Technology and Analytics revenues climbed 8.9% to $1.6B, and Contract Sales rose 9.3% to $188M. IQV raised 2025 EPS and revenue outlook but trimmed the adjusted EBITDA guidance from the prior quarter.IQVIA Holdings Analytics Inc. (IQV) has reported impressive second-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.Adjusted earnings were $2.81 per share, beating the Za ...

IQVIA (IQV) Q2 2025 Earnings Call July 22, 2025 09:00 AM ET Company ParticipantsKerri Joseph - SVP - IR & TreasuryAri Bousbib - CEO & ChairmanRon Bruehlman - EVP & CFOSalem Salem - VP - Equity ResearchShlomo Rosenbaum - Managing DirectorElizabeth Anderson - Senior MDDaniel Clark - VP - Equity ResearchJeff Garro - Managing DirectorMichael Ryskin - Managing DirectorNone - ExecutiveJailendra Singh - Managing DirectorChristine Rains - Healthcare Equity Research AssociateConference Call ParticipantsDan Leonard - ...

IQVIA (IQV) Q2 2025 Earnings Call July 22, 2025 09:00 AM ET Speaker0Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Second Quarter twenty twenty five Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. As a reminder, this call is being recorded.Thank you. I would now like to turn the call over to Kerry Joseph, Senior Vice President, ...

Q2 2025 Earnings Call July 22, 2025 IQVIA Template (V2.1.0) 1 Legal This presentation should be viewed in conjunction with IQVIA's Q2 2025 earnings call Safe Harbor Statement for Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, our third-quarter and full-year 202 ...

Exhibit 99.1 IQVIA Reports Second-Quarter 2025 Results RESEARCH TRIANGLE PARK, N.C. – (BUSINESS WIRE) – July 22, 2025 – IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended June 30, 2025. Second-Quarter 2025 Operating Results Revenue for the second quarter of $4,017 million increased 5.3 percent on a reported basi ...

The upcoming report from IQVIA Holdings (IQV) is expected to reveal quarterly earnings of $2.76 per share, indicating an increase of 4.6% compared to the year-ago period. Analysts forecast revenues of $3.96 billion, representing an increase of 3.8% year over year.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a co ...